129 related articles for article (PubMed ID: 38564373)
1. Erratum. Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE. Diabetes Care 2024;47:556-561.
Riddle MC
Diabetes Care; 2024 Jun; 47(6):1099. PubMed ID: 38564373
[No Abstract] [Full Text] [Related]
2. Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE.
Riddle MC
Diabetes Care; 2024 Apr; 47(4):556-561. PubMed ID: 38527123
[No Abstract] [Full Text] [Related]
3. It's not black and white: individualizing metformin treatment in type 2 diabetes.
Florez JC
J Clin Endocrinol Metab; 2014 Sep; 99(9):3125-8. PubMed ID: 25192381
[No Abstract] [Full Text] [Related]
4. The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data.
Lin SD; Wang JS; Hsu SR; Sheu WH; Tu ST; Lee IT; Su SL; Lin SY; Wang SY; Hsieh MC
J Diabetes Complications; 2011; 25(5):332-8. PubMed ID: 21813293
[TBL] [Abstract][Full Text] [Related]
5. Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria.
Pan Q; Xu Y; Yang N; Gao X; Liu J; Yang W; Wang G
Med Sci Monit; 2018 Dec; 24():8941-8949. PubMed ID: 30531690
[TBL] [Abstract][Full Text] [Related]
6. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes.
Brown J; Martis R; Hughes B; Rowan J; Crowther CA
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011967. PubMed ID: 28120427
[TBL] [Abstract][Full Text] [Related]
7. Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Wexler DJ; Krause-Steinrauf H; Crandall JP; Florez HJ; Hox SH; Kuhn A; Sood A; Underkofler C; Aroda VR;
Diabetes Care; 2019 Nov; 42(11):2098-2107. PubMed ID: 31391203
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide ameliorates beta-cell function, alleviates oxidative stress and inhibits low grade inflammation in young patients with new-onset type 2 diabetes.
Zhang WQ; Tian Y; Chen XM; Wang LF; Chen CC; Qiu CM
Diabetol Metab Syndr; 2018; 10():91. PubMed ID: 30564288
[TBL] [Abstract][Full Text] [Related]
9. Association between metformin use and risk of prostate cancer and its grade.
Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
[TBL] [Abstract][Full Text] [Related]
10. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
11. Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus.
Oktora MP; de Vos S; de Vries ST; Hak E; Denig P
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1395-1405. PubMed ID: 37524658
[TBL] [Abstract][Full Text] [Related]
12. Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.
Goldman-Levine JD
Pharmacotherapy; 2011 Dec; 31(12 Suppl):44S-53S. PubMed ID: 22122222
[TBL] [Abstract][Full Text] [Related]
13. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
Aroda VR; Knowler WC; Crandall JP; Perreault L; Edelstein SL; Jeffries SL; Molitch ME; Pi-Sunyer X; Darwin C; Heckman-Stoddard BM; Temprosa M; Kahn SE; Nathan DM;
Diabetologia; 2017 Sep; 60(9):1601-1611. PubMed ID: 28770322
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
Chen XM; Zhang WQ; Tian Y; Wang LF; Chen CC; Qiu CM
Cardiovasc Diabetol; 2018 Apr; 17(1):53. PubMed ID: 29636047
[TBL] [Abstract][Full Text] [Related]
15. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry.
Bacha F; Cheng P; Gal RL; Kollman C; Tamborlane WV; Klingensmith GJ; Manseau K; Wood J; Beck RW;
Horm Res Paediatr; 2018; 89(1):47-55. PubMed ID: 29131017
[TBL] [Abstract][Full Text] [Related]
16. Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands.
Gout-Zwart JJ; de Jong LA; Saptenno L; Postma MJ
Pharmacoecon Open; 2020 Jun; 4(2):321-330. PubMed ID: 31535305
[TBL] [Abstract][Full Text] [Related]
17. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
[TBL] [Abstract][Full Text] [Related]
18. Effects of diabetes mellitus and Metformin administration on prostate cancer detection at biopsy among Chinese men: a case-control study.
Hu MB; Bai PD; Wu YS; Zhang LM; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
J BUON; 2019; 24(1):227-232. PubMed ID: 30941974
[TBL] [Abstract][Full Text] [Related]
19. Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study.
Vajravelu ME; Hitt TA; Amaral S; Levitt Katz LE; Lee JM; Kelly A
Pediatr Diabetes; 2021 Sep; 22(6):861-871. PubMed ID: 33978986
[TBL] [Abstract][Full Text] [Related]
20. Erratum. Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. Diabetes care 2015;38:384-393.
DeFronzo RA; Lewin A; Patel S; Liu D; Kaste R; Woerle HJ; Broedl UC
Diabetes Care; 2015 Jun; 38(6):1173. PubMed ID: 25998298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
